Fact based stock research
Humanwell (SHSE:600079)

CNE000000QW6

Humanwell stock research in summary

humanwell.com.cn


Humanwell shares are more expensive than other comparable stocks. While they are safely financed, they show below average growth, and are poor value. We recommend evaluating whether the future of the company Humanwell is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Country China
Industry Pharmaceuticals
Index SSE Composite
Size class Large

August 6, 2021. Stock data may be delayed. Login to get the most recent research.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Humanwell from August 6, 2021.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.